Irlanda - anglès - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - sunitinib - capsule, hard - sunitinib

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - sunitinib - capsule, hard - sunitinib

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

rowex ltd - sunitinib - capsule, hard - 12.5 milligram(s) - protein kinase inhibitors; sunitinib

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

rowex ltd - sunitinib - capsule, hard - 25 milligram(s) - protein kinase inhibitors; sunitinib

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

rowex ltd - sunitinib - capsule, hard - 50 milligram(s) - protein kinase inhibitors; sunitinib

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - sunitinib 12.5mg - capsule - 12.5 mg - active: sunitinib 12.5mg excipient: croscarmellose sodium gelatin printing ink, white iron oxide red magnesium stearate mannitol microcrystalline cellulose povidone titanium dioxide - treatment of advanced renal cell carcinoma

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - sunitinib 25mg - capsule - 25 mg - active: sunitinib 25mg excipient: croscarmellose sodium gelatin printing ink, white iron oxide black iron oxide red iron oxide yellow magnesium stearate mannitol microcrystalline cellulose povidone titanium dioxide - treatment of advanced renal cell carcinoma

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - sunitinib 37.5mg - capsule - 37.5 mg - active: sunitinib 37.5mg excipient: croscarmellose sodium gelatin printing ink, black iron oxide yellow magnesium stearate mannitol microcrystalline cellulose povidone titanium dioxide - treatment of advanced renal cell carcinoma

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - sunitinib 50mg - capsule - 50 mg - active: sunitinib 50mg excipient: croscarmellose sodium gelatin printing ink, white iron oxide black iron oxide red iron oxide yellow magnesium stearate mannitol microcrystalline cellulose povidone titanium dioxide - treatment of advanced renal cell carcinoma

Israel - anglès - Ministry of Health

taro international ltd, israel - sunitinib - hard capsule - sunitinib 12.5 mg - sunitinib - sunitinib taro is indicated for:• treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. • treatment of advanced renal cell carcinoma.• treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.